Cargando…
Fetal and Neonatal Illnesses Caused or Influenced by Maternal Transplacental IgG and/or Therapeutic Antibodies Applied During Pregnancy
The human fetus is protected by the mother’s antibodies. At the end of the pregnancy, the concentration of maternal antibodies is higher in the cord blood, than in the maternal circulation. Simultaneously, the immune system of the fetus begins to work and from the second trimester, fetal IgM is prod...
Autores principales: | Berencsi, György, Szomor, Katalin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121401/ http://dx.doi.org/10.1007/978-94-007-4216-1_9 |
Ejemplares similares
-
Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors
por: Clements, Toby, et al.
Publicado: (2020) -
Benefits and Risks of IgG Transplacental Transfer
por: Ciobanu, Anca Marina, et al.
Publicado: (2020) -
Maternal and neonatal immune response to SARS-CoV-2, IgG transplacental transfer and cytokine profile
por: Rubio, Rocío, et al.
Publicado: (2022) -
Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy
por: Singh, Tulika, et al.
Publicado: (2019) -
Assessing the Presence of IgG Antibodies against Influenza Viruses in Neonates after Maternal Vaccination and Factors That May Affect the Transplacental Transfer
por: Taskou, Chrysoula, et al.
Publicado: (2023)